Increased frequency of HLA-A*02 in patients with atherosclerosis is associated with VZV seropositivity

References

• Auer, J., et al., 2002. C-reactive protein and coronary artery disease. Japanese heart journal, 43(6), 607–619.
   PubMedGoogle Scholar
• Balliuzek, M., et al., 1984. Immunogenetic characteristics of patients with ischemic heart disease. Kardiologiia, 24(10), 77–81.
   PubMed Web of Science ®Google Scholar
• Blum, J.S., et al., 2013. Pathways of antigen processing. Annual review of immunology, 31, 443–473.
   PubMed Web of Science ®Google Scholar
• Chen, K.Y., et al., 2012. Structural and functional distinctiveness of HLA-A2 allelic variants. Immunologic research, 53(1–3), 182–190.
   PubMed Web of Science ®Google Scholar
• Cochain, C., and Zernecke, A., 2016. Protective and pathogenic roles of CD8+ T cells in atherosclerosis. Basic research in cardiology, 111(6), 71
   PubMed Web of Science ®Google Scholar
• Diamantopoulos, E., et al., 2002. Association of the HLA antigens with early atheromatosis in subjects with type 2 diabetes mellitus. International angiology, 21(4), 379–383.
   PubMed Web of Science ®Google Scholar
• Ference, B.A., et al., 2017. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European heart journal, 38(32), 2459–2472.
   PubMed Web of Science ®Google Scholar
• Frey, C.R., et al., 2003. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination. The journal of infectious diseases, 188(1), 40–52.
   PubMed Web of Science ®Google Scholar
• Gershon, A.A., et al., 2015. Varicella zoster virus infection. Nature reviews disease primers, 1, 15016.
   PubMed Web of Science ®Google Scholar
• Gilden, D., et al., 2009. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. The lancet neurology, 8(8), 731–740.
   PubMed Web of Science ®Google Scholar
• Gilden, D., et al., 2015. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology, 84(19), 1948–1955.
   PubMed Web of Science ®Google Scholar
• Gisterå, A., and Hansson, G.K., 2017. The immunology of atherosclerosis. Nature reviews nephrology, 13(6), 368–380.
   PubMed Web of Science ®Google Scholar
• Hadadianpour, A., et al., 2018. High-resolution HLA-A typing in normal Iranian population. Iranian biomedical journal, 22(2), 134–137.
   PubMedGoogle Scholar
• Hansson, G.K., 2005. Inflammation, atherosclerosis, and coronary artery disease. New England journal of medicine, 352(16), 1685–1695.
   PubMed Web of Science ®Google Scholar
• Hermida, J.P., and Loro, J.F., 2004. Asymptomatic bacteriuria in women. Epidemiological, pathologic and therapeutic study. Archivos espanoles de urologia, 57(8), 784–804.
   PubMedGoogle Scholar
• Ibrahim, A.I., et al., 2005. Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. Journal of clinical virology: the official publication of the Pan American society for clinical virology, 32(1), 29–32.
   PubMed Web of Science ®Google Scholar
• James, L.M., et al., 2018. Protective effect of human leukocyte antigen (HLA) allele DRB1* 13: 02 on age-related brain Gray matter volume reduction in healthy women. EBioMedicine, 29, 31–37.
   PubMed Web of Science ®Google Scholar
• Kawai, K., and Yawn, B.P., 2017. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo clinic proceedings, 92(12), 1806.
   PubMed Web of Science ®Google Scholar
• Ku, C.-C., et al., 2002. Tropism of varicella-zoster virus for human tonsillar CD4+ T lymphocytes that express activation, memory, and skin homing markers. Journal of virology, 76(22), 11425–11433.
   PubMed Web of Science ®Google Scholar
• Meysman, P., et al., 2015. Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgia. Journal of virology, 89(2), 962–969.
   PubMed Web of Science ®Google Scholar
• Moffat, J.F., et al., 1995. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. Journal of virology, 69(9), 5236–5242.
   PubMed Web of Science ®Google Scholar
• Mundkur, L.A., et al., 2012. Human cytomegalovirus neutralising antibodies and increased risk of coronary artery disease in Indian population. Heart, 98(13), 982–987.
   PubMed Web of Science ®Google Scholar
• Nagel, M.A., et al., 2011. Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology, 77(4), 364–370.
   PubMed Web of Science ®Google Scholar
• Nagel, M.A., et al., 2013. Varicella-zoster virus vasculopathy Immune characteristics of virus-infected arteries. Neurology, 80(1), 62–68.
   PubMed Web of Science ®Google Scholar
• Nagel, M.A., and Gilden, D., 2014. Neurological complications of VZV reactivation. Current opinion in neurology, 27(3), 356–360.
   PubMed Web of Science ®Google Scholar
• Ozawa, A., et al., 1999. HLA-A33 and -B44 and susceptibility to postherpetic neuralgia (PHN). Tissue antigens, 53(3), 263–268.
   PubMedGoogle Scholar
• Palikhe, A., et al., 2008. Lymphotoxin alpha LTA + 496C allele is a risk factor for periodontitis in patients with coronary artery disease. Tissue antigens, 71(6), 530–537.
   PubMedGoogle Scholar
• Paul, V.S.V., et al., 2016. Quantification of various inflammatory cells in advanced atherosclerotic plaques. Journal of clinical and diagnostic research, 10(5), 35–38.
   Web of Science ®Google Scholar
• Pesonen, E., et al., 2007. Dual role of infections as risk factors for coronary heart disease. Atherosclerosis, 192(2), 370–375.
   PubMed Web of Science ®Google Scholar
• Pisapia, D.J., and Lavi, E., 2016. VZV, temporal arteritis, and clinical practice: false positive immunohistochemical detection due to antibody cross-reactivity. Experimental and molecular pathology, 100(1), 114–115.
   PubMed Web of Science ®Google Scholar
• Rafieian-Kopaei, M., et al., 2014. Atherosclerosis: process, indicators, risk factors and new hopes. International journal of preventive medicine, 5, (8), 927–946.
   Google Scholar
• Reguzova, A.Y., et al., 2015. Peptide–MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development. Expert review of vaccines, 14(1), 69–84.
   PubMed Web of Science ®Google Scholar
• Rosenfeld, M.E., and Campbell, L.A., 2011. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thrombosis and haemostasis, 106(5), 858–867.
   PubMed Web of Science ®Google Scholar
• Sanchez‐Mazas, A., et al., 2017. The HLA-B landscape of Africa: Signatures of pathogen-driven selection and molecular identification of candidate alleles to malaria protection. Molecular ecology, 26(22), 6238–6252.
   PubMed Web of Science ®Google Scholar
• Sato, M., et al., 2002. Association of HLA-A* 3303-B* 4403-DRB1* 1302 haplotype, but not of TNFA promoter and NKp30 polymorphism, with postherpetic neuralgia (PHN) in the Japanese population. Genes and immunity, 3(8), 477–481.
   PubMed Web of Science ®Google Scholar
• Shah, P.K., et al., 2014. Vaccine for atherosclerosis. Journal of the American college of cardiology, 64(25), 2779–2791.
   PubMed Web of Science ®Google Scholar
• Shaiegan, M., et al., 2011. Allele frequencies of HLA-A, B and DRB1 among people of Fars ethnicity living in Tehran. Iranian journal of blood and cancer, 3(4), 55–59.
   Google Scholar
• Shapiro, M.D., and Fazio, S., 2016. From lipids to inflammation: new approaches to reducing atherosclerotic risk. Circulation research, 118(4), 732–749.
   PubMed Web of Science ®Google Scholar
• Sproston, N.R., and Ashworth, J.J., 2018. Role of C-reactive protein at sites of inflammation and infection. Frontiers in immunology, 9, 754.
   PubMed Web of Science ®Google Scholar
• Stylianou, I.M., et al., 2012. Genetic basis of atherosclerosis: insights from mice and humans. Circulation research, 110(2), 337–355.
   PubMed Web of Science ®Google Scholar
• van der Heiden, P.L., et al., 2009. Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantation. Journal of virology, 83(14), 7361–7364.
   PubMed Web of Science ®Google Scholar
• Weitzman, D., et al., 2013. A population based study of the epidemiology of Herpes Zoster and its complications. The journal of infection, 67(5), 463–469.
   PubMed Web of Science ®Google Scholar
• Wigren, M., et al., 2012. Lymphocytes in atherosclerosis. Clinica chimica acta; international journal of clinical chemistry, 413(19–20), 1562–1568.
   PubMed Web of Science ®Google Scholar
• Williams, T.M., 2001. Human leukocyte antigen gene polymorphism and the histocompatibility laboratory. The journal of molecular diagnostics, 3(3), 98–104.
   PubMed Web of Science ®Google Scholar
• Yaiw, K.-C., et al., 2013. High prevalence of human cytomegalovirus in carotid atherosclerotic plaques obtained from Russian patients undergoing carotid endarterectomy. Herpesviridae, 4(1), 3.
   PubMedGoogle Scholar